Skip to main content
Howland Crosswell, MD, Pediatric Hematology & Oncology, Greenville, SC

Howland E Crosswell MD


Physician

Join to view full profile
  • 900 W Faris Rd2ND floorGreenville, SC 29605

  • Phone+1 864-455-8898

  • Fax+1 864-455-5164

Dr. Crosswell is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2006
  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Pediatrics, 1997 - 2000
  • University of South Carolina School of Medicine
    University of South Carolina School of MedicineClass of 1997
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1997

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2014 - 2027
  • SC State Medical License
    SC State Medical License 2000 - 2027
  • WV State Medical License
    WV State Medical License 2015 - 2016
  • GA State Medical License
    GA State Medical License 2003 - 2007
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013, 2015-2017

Publications & Presentations

PubMed

Lectures

  • 'Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYA) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Seattle Genetics Highlights Additional Analyses from ECHELON-1 Phase 3 Clinical Trial of ADCETRIS
    Seattle Genetics Highlights Additional Analyses from ECHELON-1 Phase 3 Clinical Trial of ADCETRISDecember 2nd, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: